Phase I/II study of azacitidine, docetaxel, and prednisone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel-based therapy

Rakesh Singal, Kavitha Ramachandran, Edna Gordian, Carlos Quintero, Wei Zhao, Isildinha M. Reis

Research output: Contribution to journalArticlepeer-review

30 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I/II study of azacitidine, docetaxel, and prednisone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel-based therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences